Label: information for the user
Glucose 5% and sodium chloride 0.33% Baxter solution for infusion
Active ingredients: sodium chloride, glucose
Read this label carefully before starting to use the medication,because it contains important information for you.
-If you experience any adverse effects, consult your doctor or nurse, even if they are not listed in this label. See section 4.
This medication is called Glucose 5% and Sodium Chloride 0.33% Baxter solution for infusion, but it will be referred to as “Glucose 5% and Sodium Chloride 0.33% Baxter” in the rest of this label
1.What is Glucose 5% and Sodium Chloride 0.33% Baxter and how it is used
2.What you need to know before you are given Glucose 5% and Sodium Chloride 0.33% Baxter
3.How you will be given Glucose 5% and Sodium Chloride 0.33% Baxter
4.Possible adverse effects
5.Storage of Glucose 5% and Sodium Chloride 0.33% Baxter
6.Contents of the package and additional information
Glucosa 5% and sodium chloride 0.33% Baxter is a solution of the following substances in water:
Glucose is one of the body's energy sources. This solution provides 200 kilocalories per liter. Sodium and chloride are chemical substances found in the blood.
Glucosa 5% and sodium chloride 0.33% Baxter is used:
for treatment, if the volume of blood in the blood vessels is low (hypovolemia).
Inform your doctor if you have or have had any of the following clinical situations:
This may increase the risk of low sodium levels in the blood and can cause headache, nausea, convulsions, lethargy, coma, brain inflammation, and death. Brain inflammation increases the risk of death and brain damage. People at higher risk of brain inflammation are:
When you are receiving this solution, your doctor may take blood and urine samples to control:
As Glucosa 5% and 0.33% Sodium Chloride Baxter contains sugar (glucose), it may increase blood sugar levels (hyperglycemia). If this occurs, your doctor may:
This is particularly important:
- If you are diabetic.
- If you have not been eating well or have been drinking too much alcohol for a long time.
- If you have recently had a brain injury (acute cerebral stroke). High blood sugar levels can worsen the effects of brain injury and affect your recovery.
- If you have had a head injury in the last 24 hours. Your doctor should take into account if you are receiving parenteral nutrition (nutrition administered through a vein). During prolonged treatments with Glucosa 5% and 0.33% Sodium Chloride Baxter, you may need to receive additional nutrition. Your doctor should monitor your blood potassium levels to avoid them decreasing too much (hypokalemia).
Special care should be taken when administering this solution to children, infants, and newborns (especially premature babies and those with low birth weight). Children, infants, and newborns may not have a good ability to handle the chemical substances in the solution.
The smallest children are at higher risk of developing low or high blood sugar levels and therefore require careful monitoring during treatment to ensure adequate control of blood sugar levels. Low blood sugar in newborns can cause prolonged convulsions, coma, and brain damage. High blood sugar has been associated with brain hemorrhage, bacterial or fungal infections, eye damage (retinopathy of prematurity), intestinal infections, respiratory problems, prolonged hospital stay, and death.
Children are at higher risk of developing low sodium levels in the blood (hypontremia hipo-osmolar). Hypontremia can cause headache, nausea, convulsions, lethargy, coma, brain inflammation (cerebral edema), and death. Acute hypontremia encephalopathy is a severe complication, especially in children.
Your doctor knows all this and will carefully monitor the amount of chemical substances such as glucose (sugar), sodium, and chloride in your child's blood (plasma electrolytes).
Inform your doctor or nurse if you are using, or have recently used, any other medication.
It is particularly important to inform your doctor if you are taking:
- Corticosteroids (anti-inflammatory medications).
These medications can cause the body to accumulate sodium and water, leading to swelling of tissues due to fluid accumulation under the skin (edema) or high blood pressure (hypertension).
Some medications act on the vasopressin hormone. These may include:
Other medications that may affect or be affected by Glucosa 5% and 0.33% Sodium Chloride Baxter are:
Ask your doctor about what you can eat or drink.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or nurse before using this medication.
Glucosa 5% and 0.33% Sodium Chloride Baxter can be used safely during pregnancy and breastfeeding.
However, if another medication is added to the infusion solution during pregnancy or breastfeeding, you should:
Glucosa 5% and 0.33% Sodium Chloride Baxter does not affect your ability to drive or use machines.
Gluconate 5% and Sodium Chloride 0.33% Baxterwill be administered by a doctor or a nurse. Your doctor will decide how much you need and when you should receive it. This will depend on your age, weight, physical condition, and the reason for the treatment. The amount you receive may also be influenced by other treatments you are receiving.
You should not receiveGluconate 5% and Sodium Chloride 0.33% Baxterif there are particles floating in the solution or if the container is damaged in any way.
Before and during the infusion, your doctor will monitor:
Any unused remainder of the solution should be discarded. You should not receive Gluconate 5% and Sodium Chloride 0.33% Baxter from a bag that has already been started.
If you receive too much of the Gluconate 5% and Sodium Chloride 0.33% Baxter solution or if you receive it too quickly, you may experience the following symptoms:
-dry mouth due to lack of water in the body tissues (dehydration)
-thirst
-increased urine production (osmotic diuresis)
-blurred vision
-fatigue.
If you experience these symptoms, inform your doctor immediately. The infusion will be stopped and you will receive treatment based on your symptoms.
If a medication has been added to Gluconate 5% and Sodium Chloride 0.33% Baxter before the excessive administration, the medication may also cause symptoms. You should read the list of possible symptoms in the medication's package insert.
If you have any other questions about the use of this product, ask your doctor or nurse.
Like all medications,Glucosa 5% and Sodium Chloride 0.33% Baxtercan produce adverse effects, although not all people will experience them.
Adverse effects may be related toGlucosa 5% and Sodium Chloride 0.33% Baxter. These include:
Adverse effects may bedue to the administration technique.These include:
If a medication has been added to the infusion solution, it may also produce adverse effects. These adverse effects will depend on the added medication. You should read the list of possible symptoms in the prospectus of the added medication.
Reporting Adverse Effects:
If you experience any type of adverse effect, consult your doctor or nurse, even if it is a possible adverse effect that does not appear in this prospectus.If any of them occur, the infusion should be stopped.You can also report them directly through the Spanish System of Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medication
Keep out of sight and reach of children.
Do not store at a temperature above 25°C.
Glucose 5% and Sodium Chloride 0.33% BaxterDO NOT administer after the expiration date that appears on the bag after CAD. The expiration date is the last day of the month indicated.
Do not administer Glucose 5% and Sodium Chloride 0.33% Baxter if there are particles floating in the solution or if the container is damaged in any way.
-glucose: 50 g per liter
-sodium chloride: 3.3 g per liter
The other component is water for injectable preparations.
Glucose 5% and sodium chloride 0.33% Baxteris a transparent solution, free of visible particles. It is presented in plastic bags of polyolefin/polyamide (Viaflo). Each bag is packaged in a protective plastic overbag.
The bag sizes are:
The bags are packaged in cardboard boxes. Each cardboard box contains one of the following quantities:
Only some sizes of containers may be commercially available
Baxter S.L.
Pouet de Camilo 2, 46394 Ribarroja del Turia (Valencia)
Responsible for manufacturing | |
Bieffe Medital S.A. Ctra. Biescas-Senegüé s/n, 22666 Sabiñánigo (Huesca), Spain |
Date of the last review of this leaflet:October 2023
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/
Use only if the solution is transparent, free of visible particles, and the container is not damaged. Administer immediately after connecting the infusion equipment.
Do not remove the bag from its protective overbag until it is ready for use.
The inner bag maintains the sterility of the product.
Do not connect plastic containers in series. This type of use may cause gas embolism due to residual air carried from the primary container before the administration of the liquid in the secondary container is complete.
The pressurization of solutions in flexible plastic containers to increase flow rates may cause a gas embolism if the residual air is not completely evacuated before administration.
The use of an intravenous administration set with a ventilation filter in the open position may cause a gas embolism. This type of intravenous administration set with the ventilation filter in the open position should not be used with flexible plastic containers.
The solution must be administered with a sterile device using an aseptic technique. The device must be primed with the solution to prevent air from entering the system.
Medicines added may be introduced before or during infusion through the injection port. When adding medicines, check isotonicity before parenteral administration.
From a physical-chemical point of view, the solution containing added medicines should be used immediately unless the chemical and physical stability has been established in use.
From a microbiological point of view, the diluted solution should be used immediately. If not used immediately, the storage conditions and time before use are the responsibility of the user and should not normally exceed 24 hours at 2-8°C, unless the addition of medicines has been carried out in controlled and validated aseptic conditions.
Discard after single use.
Discard partially used containers.
Do not reconnect partially used bags.
a.Remove the Viaflo bag from the protective overbag immediately before use.
b.Check for small leaks by pressing the inner bag firmly. If leaks are detected, discard the solution, as it may not be sterile.
c.Check the transparency of the solution and the absence of foreign particles. Discard the solution if it is not transparent or contains foreign particles.
Use sterile material for preparation and administration.
a.Hang the container by the loop
b.-Remove the plastic protector from the outlet in the lower part of the container.
-Hold one hand on the small handle of the outlet tube.
-Hold the other hand on the large handle of the closure cap and turn it.
-The cap will come off.
c.Use an aseptic technique to prepare the infusion
d.Connect the administration equipment. Consult the equipment instructions for connection, priming, and administration of the solution.
Warning: Added medicines may be incompatible. (see below the section 5 "incompatibilities of added medicines")
a.Disinfect the injection port
b.Using a syringe with a 19gauge (1.10 mm)to 22gauge (0.70 mm)needle, prick the injection port and inject.
c.Mix the medication and solution completely. For high-density medicines, such as potassium chloride, gently tap the tubes while in the vertical position and mix.
Caution: Do not store bags with added medication.
a.Close the clamp of the equipment
b.Disinfect the injection port
c.Using a syringe with a 19gauge (1.10 mm)to 22gauge (0.70 mm)needle, prick the injection port and inject.
d.Remove the container from the foot of the drip chamber and/or turn it to put it in the vertical position.
e.Empty both tubes by gently tapping them while the container is in the vertical position.
f.Mix the solution and medication completely.
g.Put the container back in the use position, reopen the clamp, and continue the administration.
Before use, the physical and chemical stability of any additional medication to the pH of the solutionGlucose 5% and sodium chloride 0.33% Baxterin the Viaflo container must be established.
From a physical-chemical point of view, the solution containing added medicines should be used immediately unless the chemical and physical stability has been established in use.
From a microbiological point of view, the diluted solution should be used immediately. If not used immediately, the storage conditions and time before use are the responsibility of the user and should not normally exceed 24 hours at 2-8°C, unless the addition of medicines has been carried out in controlled and validated aseptic conditions.
As with all parenteral solutions, the compatibility of added medicines with the Viaflo bag solution must be verified before addition.
It is the responsibility of the doctor to judge the incompatibility of the added medication withGlucose 5% and sodium chloride 0.33% Baxterby examining any eventual change in color and/or precipitation, insoluble complexes, or appearance of crystals. The package insert of the medicine to be added should be consulted.
Before adding a medicine, verify thatit is soluble and stable in water at the pH of Glucose 5% and sodium chloride 0.33% Baxter (pH 3.5 - 6.5).
When adding compatible medication to Glucose 5% and sodium chloride 0.33% Baxter, the solution should be administered immediately unless the chemical and physical stability has been established in use. As a guide, the following medicines are incompatible withGlucose 5% and sodium chloride 0.33% Baxter(this is not an exhaustive list):
-Sodium ampicillin
-Mitomycin
-Erythromycin lactobionate
-Human insulin
As it contains glucose,Glucose 5% and sodium chloride 0.33% Baxtershould not be administered with whole blood through the same infusion equipment, due to the possibility of hemolysis and agglutination.
Medicines whose incompatibility is known should not be used.
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.